لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Kang SS; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Lee SH; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Baek S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yang SM; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han YJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim MH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han H; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Na K; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YT; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Yun MR; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Curtin JC; Janssen R&D, Spring House, Pennsylvania., Patel B; Janssen R&D, Spring House, Pennsylvania., Bergiers I; Janssen R&D, Beerse, Belgium., Pyo KH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea.

المصدر: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1748-1764.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/pharmacology , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/immunology , Squamous Cell Carcinoma of Head and Neck*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/immunology , Tumor Microenvironment*/drug effects , Tumor Microenvironment*/immunology, Humans ; Animals ; Mice ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/immunology ; Xenograft Model Antitumor Assays ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; B7-H1 Antigen/metabolism ; Cell Line, Tumor

المؤلفون: Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Universitat Autonoma de Barcelona, Barcelona, Spain. Electronic address: efelip@vhio.net., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Gutiérrez V; Medical Oncology Department, Hospital Regional Universitario de Málaga y Virgen de la Victoria, IBIMA, Málaga, Spain., Alip A; Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Besse B; Paris-Saclay University, Gustave Roussy, Villejuif, France., Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Spira AI; Virginia Cancer Specialists, Fairfax, VA, USA., Girard N; Institut du Thorax Curie-Montsouris, Paris, France; Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, Versailles, France., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Gadgeel SM; Department of Internal Medicine, Henry Ford Cancer Institute, Detroit, MI, USA., Yang JC; National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan., Yamamoto S; Ehime University Hospital, Toon, Ehime., Azuma K; Kurume University School of Medicine, Kurume, Japan., Kim YJ; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Lee KH; Medical Department, Chungbuk National University Hospital, Cheongju, Republic of Korea., Danchaivijitr P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Ferreira CG; Oncoclinicas&CO/MedSir, Rio de Janeiro, Brazil., Cheng Y; Jilin Cancer Hospital, Changchun, China., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yıldırım Beyazıt University, Ankara, Turkey., Chang GC; School of Medicine and Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan., Wang CC; Division of Pulmonary & Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Prabhash K; Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India., Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Stroyakovskiy D; Healthcare Department, Moscow City Oncology Hospital No. 62, Moscow, Russia., Paz-Ares L; CNIO-H120 Lung Cancer Unit, University Hospital 12 de Octubre, Universidad Complutense de Madrid and CIBERONC, Madrid, Spain., Rodriguez-Cid JR; Médica Sur, Ciudad de México, CDMX, Mexico., Martin C; Thoracic Oncology Unit and Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Campelo MRG; Medical Oncology, Hospital Universitario A Coruña, A Coruña, Spain., Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan., Nguyen D; City of Hope National Medical Center, Duarte, CA, USA., Tomasini P; Aix Marseille University, APHM, INSERM, NCRS, CRCM, Hôpital de la Timone, Multidisciplinary Oncology & Therapeutic Innovations Department, Marseille, France., Gottfried M; Meir Medical Center, Kfar-Sava, Israel., Dooms C; Respiratory Oncology Unit, University Hospitals Leuven, Leuven, Belgium., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy., Schuler M; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany., Gelatti ACZ; Uniao Brasileira de Educaçao e Assistencia-Hospital Sao Lucas da PUCRS, Porto Alegre-RS, Brazil., Owen S; Department of Oncology, McGill University, Montréal, QC, Canada., Perdrizet K; William Osler Health System, Brampton, ON, Canada., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA., Curtin JC; Janssen Research & Development, Spring House, PA, USA., Zhang J; Janssen Research & Development, Spring House, PA, USA., Gormley M; Janssen Research & Development, Spring House, PA, USA., Sun T; Janssen Research & Development, Raritan, NJ, USA., Panchal A; Janssen Research & Development, High Wycombe, UK., Ennis M; Janssen Research & Development, Spring House, PA, USA., Fennema E; Janssen Research & Development, San Diego, CA, USA., Daksh M; Janssen Research & Development, Raritan, NJ, USA., Sethi S; Janssen Research & Development, Spring House, PA, USA., Bauml JM; Janssen Research & Development, Spring House, PA, USA., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

المؤلفون: Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. CBC1971@yuhs.ac., Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea., Spira AI; Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA., Gomez JE; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Haura EB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Cho EK; Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Lee KH; Chungbuk National University Hospital, Cheongju, Republic of Korea., Minchom A; Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK., Lee JS; Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Han JY; National Cancer Center, Gyeonggi-do, Republic of Korea., Nagasaka M; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA., Sabari JK; New York University School of Medicine, New York, NY, USA., Ou SI; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA., Lorenzini P; Janssen R&D, Spring House, PA, USA., Bauml JM; Janssen R&D, Spring House, PA, USA., Curtin JC; Janssen R&D, Spring House, PA, USA., Roshak A; Janssen R&D, Spring House, PA, USA., Gao G; Janssen R&D, Spring House, PA, USA., Xie J; Janssen R&D, Spring House, PA, USA., Thayu M; Janssen R&D, Spring House, PA, USA., Knoblauch RE; Janssen R&D, Spring House, PA, USA., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Nature medicine [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2577-2585. Date of Electronic Publication: 2023 Sep 14.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Prospective Studies ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Mutation/genetics ; Aniline Compounds/therapeutic use ; ErbB Receptors/genetics

المؤلفون: Park K; Dept of Thoracic/Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center, Texas., Sabari JK; NYU School of Medicine, New York, NY, USA., Haura EB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Shu CA; Columbia University Medical Center, New York, NY, USA., Spira A; Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA., Salgia R; City of Hope, Duarte, CA, USA., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Govindan R; Washington University School of Medicine, St. Louis, MO, USA., Bauml JM; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Curtin JC; Janssen R&D, Spring House, PA, USA., Xie J; Janssen R&D, Spring House, PA, USA., Roshak A; Janssen R&D, Spring House, PA, USA., Lorenzini P; Janssen R&D, Spring House, PA, USA., Millington D; Janssen R&D, Spring House, PA, USA., Thayu M; Janssen R&D, Spring House, PA, USA., Knoblauch RE; Janssen R&D, Spring House, PA, USA., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: cbc1971@yuhs.ac.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Apr; Vol. 178, pp. 166-171. Date of Electronic Publication: 2023 Feb 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific* , Carcinoma, Non-Small-Cell Lung*/drug therapy , Drug-Related Side Effects and Adverse Reactions* , Immune System Diseases* , Lung Neoplasms*, Animals ; Humans ; ErbB Receptors ; Pupa

المؤلفون: Viteri S; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain., Minchom A; Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK., Bazhenova L; University of California San Diego, CA, USA., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA., Bauml JM; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Shell SA; Guardant Health, Redwood City, CA, USA., Schaffer M; Janssen R&D, Spring House, PA, USA., Gu J; Janssen R&D, Spring House, PA, USA., Rose JB; Janssen R&D, Spring House, PA, USA., Curtin JC; Janssen R&D, Spring House, PA, USA., Mahadevia P; Janssen R&D, Spring House, PA, USA., Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, Paris, France.

المصدر: Molecular oncology [Mol Oncol] 2023 Feb; Vol. 17 (2), pp. 230-237. Date of Electronic Publication: 2022 Nov 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/diagnosis , Lung Neoplasms*/genetics, Humans ; Mutagenesis, Insertional/genetics ; ErbB Receptors/genetics ; Mutation/genetics ; Exons/genetics ; Genomics ; Protein Kinase Inhibitors

المؤلفون: Jatkoe T; Janssen Research & Development, Spring House, Pennsylvania. Electronic address: swang8@its.jnj.com., Wang S; Janssen Research & Development, Spring House, Pennsylvania. Electronic address: tjatkoe@its.jnj.com., Odegaard JI; Guardant Health, Redwood City, California., Velasco Roth AM; Thermo Fisher Scientific, Carlsbad, California., Osgood D; Thermo Fisher Scientific, Carlsbad, California., Martinez G; Janssen Research & Development, Spring House, Pennsylvania., Lucas P; Thermo Fisher Scientific, Carlsbad, California., Curtin JC; Janssen Research & Development, Spring House, Pennsylvania., Karkera J; Janssen Research & Development, Spring House, Pennsylvania.

المصدر: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Nov; Vol. 24 (11), pp. 1181-1188. Date of Electronic Publication: 2022 Aug 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnosis , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/diagnosis , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Patient Selection ; Mutagenesis, Insertional/genetics ; Protein Kinase Inhibitors/therapeutic use ; ErbB Receptors/genetics ; Exons/genetics ; Mutation